MicroRNA Levels as Prognostic Markers for the Differentiation Potential of Human Mesenchymal Stromal Cell Donors.

The ability of human mesenchymal stromal/stem cells (hMSCs) to differentiate into various mesenchymal cell lineages makes them a promising cell source for the use in tissue repair strategies. Since the differentiation potential of hMSCs differs between donors, it is necessary to establish biomarkers for the identification of donors with high differentiation potential. In this study, we show that microRNA (miRNA) expression levels are effective for distinguishing donors with high differentiation potential from low differentiation potential. Twenty hMSC donors were initially tested for marker expression and differentiation potential. In particular, the chondrogenic differentiation potential was evaluated on the basis of histological matrix formation, mRNA expression levels of chondrogenic marker genes, and quantitative glycosaminoglycan deposition. Three donors out of twenty were identified as donors with high chondrogenic potential, whereas nine showed moderate and eight showed low chondrogenic potential. Expression profiles of miRNAs involved in chondrogenesis and cartilage homeostasis were used for the distinction between high-performance hMSCs and low-performance hMSCs. Global mRNA expression profiles of the donors before the onset of chondrogenic differentiation revealed minor differences in gene expression between low and high chondrogenic performers. However, analysis of miRNA expression during a 7-day differentiation period identified miR-210 and miR-630 as positive regulators of chondrogenesis. In contrast, miR-181 and miR-34a, which are negative regulators of chondrogenesis, were upregulated during differentiation in low-performing donors. In conclusion, profiling of hMSC donors for a specific panel of miRNAs may have a prognostic value for selecting donors with high differentiation potential to improve hMSC-based strategies for tissue regeneration.

[1]  C. V. van Blitterswijk,et al.  The effect of donor variation and senescence on endothelial differentiation of human mesenchymal stromal cells. , 2013, Tissue engineering. Part A.

[2]  M. Reinders,et al.  Predicting the therapeutic efficacy of MSC in bone tissue engineering using the molecular marker CADM1. , 2013, Biomaterials.

[3]  C. V. van Blitterswijk,et al.  Cell sources for articular cartilage repair strategies: shifting from monocultures to cocultures. , 2013, Tissue engineering. Part B, Reviews.

[4]  G. Stein,et al.  miR-218 Directs a Wnt Signaling Circuit to Promote Differentiation of Osteoblasts and Osteomimicry of Metastatic Cancer Cells* , 2012, The Journal of Biological Chemistry.

[5]  Seyed Hassan Paylakhi,et al.  A microRNA signature associated with chondrogenic lineage commitment , 2012, Journal of Genetics.

[6]  J. Alm,et al.  MicroRNAs miR‐96, miR‐124, and miR‐199a regulate gene expression in human bone marrow‐derived mesenchymal stem cells , 2012, Journal of cellular biochemistry.

[7]  Wei Wei,et al.  MiR‐26 controls LXR‐dependent cholesterol efflux by targeting ABCA1 and ARL7 , 2012, FEBS letters.

[8]  P. Lui,et al.  Effect of in vitro passaging on the stem cell-related properties of tendon-derived stem cells-implications in tissue engineering. , 2012, Stem cells and development.

[9]  M. Goldring,et al.  Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis. , 2012, Trends in molecular medicine.

[10]  Haibo Zhou,et al.  miR-30 Family Members Negatively Regulate Osteoblast Differentiation* , 2012, The Journal of Biological Chemistry.

[11]  D. Ying,et al.  MicroRNA-145 Regulates Chondrogenic Differentiation of Mesenchymal Stem Cells by Targeting Sox9 , 2011, PloS one.

[12]  S. Kauppinen,et al.  mRNA expression profiling reveals conserved and non-conserved miR-140 targets , 2011, RNA biology.

[13]  X. Chen,et al.  Identification of MicroRNAs Involved in Hypoxia- and Serum Deprivation-Induced Apoptosis in Mesenchymal Stem Cells , 2011, International journal of biological sciences.

[14]  A. Dopazo,et al.  miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells , 2011, Cell Death and Differentiation.

[15]  Clemens A van Blitterswijk,et al.  Trophic effects of mesenchymal stem cells increase chondrocyte proliferation and matrix formation. , 2011, Tissue engineering. Part A.

[16]  T. Moccetti,et al.  Adult Human Adipose Tissue Contains Several Types of Multipotent Cells , 2011, Journal of cardiovascular translational research.

[17]  T. Karlsen,et al.  Human primary articular chondrocytes, chondroblasts-like cells, and dedifferentiated chondrocytes: differences in gene, microRNA, and protein expression and phenotype. , 2011, Tissue engineering. Part C, Methods.

[18]  Damian Szklarczyk,et al.  The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..

[19]  M. Ochi,et al.  Silencing microRNA-34a inhibits chondrocyte apoptosis in a rat osteoarthritis model in vitro. , 2010, Rheumatology.

[20]  Farshid Guilak,et al.  Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype , 2010, Nature Protocols.

[21]  J. Song,et al.  MicroRNA-221 Regulates Chondrogenic Differentiation through Promoting Proteosomal Degradation of Slug by Targeting Mdm2* , 2010, The Journal of Biological Chemistry.

[22]  J. Veltman,et al.  Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. , 2010, Stem cells and development.

[23]  J. Klein-Nulend,et al.  Buccal fat pad, an oral access source of human adipose stem cells with potential for osteochondral tissue engineering: an in vitro study. , 2010, Tissue engineering. Part C, Methods.

[24]  W. Koh,et al.  Analysis of deep sequencing microRNA expression profile from human embryonic stem cells derived mesenchymal stem cells reveals possible role of let-7 microRNA family in downstream targeting of Hepatic Nuclear Factor 4 Alpha , 2010, BMC Genomics.

[25]  Yong-ping Su,et al.  More insight into mesenchymal stem cells and their effects inside the body , 2010, Expert opinion on biological therapy.

[26]  J. Pelletier,et al.  Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes , 2009, BMC musculoskeletal disorders.

[27]  Raquel Norel,et al.  MicroRNA‐23b cluster microRNAs regulate transforming growth factor‐beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads , 2009, Hepatology.

[28]  S. Koelling,et al.  Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. , 2009, Cell stem cell.

[29]  E. Alsberg,et al.  Chondrogenic differentiation of human mesenchymal stem cell aggregates via controlled release of TGF-beta1 from incorporated polymer microspheres. , 2009, Journal of biomedical materials research. Part A.

[30]  Christian von Mering,et al.  STRING 8—a global view on proteins and their functional interactions in 630 organisms , 2008, Nucleic Acids Res..

[31]  P. Emery,et al.  Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. , 2008, Arthritis and rheumatism.

[32]  M. Baumann,et al.  A number of bone marrow mesenchymal stem cells but neither phenotype nor differentiation capacities changes with age of rats. , 2007, Molecules and cells.

[33]  Dirk Strunk,et al.  Two steps to functional mesenchymal stromal cells for clinical application , 2007, Transfusion.

[34]  C. V. van Blitterswijk,et al.  Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[35]  M. Baumann,et al.  Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats. , 2007, Stem cells and development.

[36]  L. Lim,et al.  A microRNA component of the p53 tumour suppressor network , 2007, Nature.

[37]  R. Tuan,et al.  Comparison of Proliferative and Multilineage Differentiation Potential of Human Mesenchymal Stem Cells Derived from Umbilical Cord and Bone Marrow , 2007, Stem cells.

[38]  Clemens A van Blitterswijk,et al.  A rapid and efficient method for expansion of human mesenchymal stem cells. , 2007, Tissue engineering.

[39]  George A. Calin,et al.  A MicroRNA Signature of Hypoxia , 2006, Molecular and Cellular Biology.

[40]  T. Dalmay,et al.  The cartilage specific microRNA‐140 targets histone deacetylase 4 in mouse cells , 2006, FEBS letters.

[41]  Shin‐Sung Kang,et al.  Wnt-5a is involved in TGF-beta3-stimulated chondrogenic differentiation of chick wing bud mesenchymal cells. , 2006, The international journal of biochemistry & cell biology.

[42]  Jian Fei Wang,et al.  A Novel Role for GADD45β as a Mediator of MMP-13 Gene Expression during Chondrocyte Terminal Differentiation* , 2005, Journal of Biological Chemistry.

[43]  Techung Lee,et al.  Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture , 2005, Journal of cellular physiology.

[44]  A. Papavassiliou,et al.  JNK/ERK–AP-1/Runx2 induction “paves the way” to cartilage load-ignited chondroblastic differentiation , 2005, Histochemistry and Cell Biology.

[45]  Gordon K. Smyth,et al.  limmaGUI: A graphical user interface for linear modeling of microarray data , 2004, Bioinform..

[46]  D J Prockop,et al.  Donor variation in the growth properties and osteogenic potential of human marrow stromal cells , 1999, Journal of cellular biochemistry.

[47]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[48]  R. Derynck,et al.  Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.

[49]  T. Kawamoto,et al.  Molecular characterization of the novel basic helix-loop-helix protein DEC1 expressed in differentiated human embryo chondrocytes. , 1997, Biochemical and biophysical research communications.

[50]  S. O’Driscoll,et al.  Relationship of donor site to chondrogenic potential of periosteum in vitro , 1994, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[51]  J. Hesketh,et al.  The control of chondrocyte differentiation during endochondral bone growth in vivo: changes in TGF-beta and the proto-oncogene c-myc. , 1993, Journal of cell science.

[52]  E. Wagner,et al.  Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes , 1984, Nature.

[53]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[54]  F. Luyten,et al.  Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. , 2001, Arthritis and rheumatism.

[55]  R. Mitchell,et al.  Expression of the c-fos gene during differentiation. , 1987, Advances in experimental medicine and biology.